CN101270096B - 一种合成缬沙坦的方法 - Google Patents
一种合成缬沙坦的方法 Download PDFInfo
- Publication number
- CN101270096B CN101270096B CN2007100383460A CN200710038346A CN101270096B CN 101270096 B CN101270096 B CN 101270096B CN 2007100383460 A CN2007100383460 A CN 2007100383460A CN 200710038346 A CN200710038346 A CN 200710038346A CN 101270096 B CN101270096 B CN 101270096B
- Authority
- CN
- China
- Prior art keywords
- compound
- valsartan
- azide
- solvent
- benzyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000004072 C09CA03 - Valsartan Substances 0.000 title claims abstract description 26
- SJSNUMAYCRRIOM-QFIPXVFZSA-N valsartan Chemical compound C1=CC(CN(C(=O)CCCC)[C@@H](C(C)C)C(O)=O)=CC=C1C1=CC=CC=C1C1=NN=N[N]1 SJSNUMAYCRRIOM-QFIPXVFZSA-N 0.000 title claims abstract description 26
- 229960004699 valsartan Drugs 0.000 title claims abstract description 26
- 238000000034 method Methods 0.000 title claims abstract description 21
- 230000002194 synthesizing effect Effects 0.000 title claims abstract description 10
- 229960004295 valine Drugs 0.000 claims abstract description 12
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 10
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 10
- 238000006243 chemical reaction Methods 0.000 claims abstract description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 56
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical group [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 claims description 34
- 239000002904 solvent Substances 0.000 claims description 25
- ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 claims description 23
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 18
- -1 pentanoyl compound Chemical class 0.000 claims description 16
- 239000012044 organic layer Substances 0.000 claims description 14
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 12
- 239000010410 layer Substances 0.000 claims description 10
- NPDACUSDTOMAMK-UHFFFAOYSA-N 4-Chlorotoluene Chemical compound CC1=CC=C(Cl)C=C1 NPDACUSDTOMAMK-UHFFFAOYSA-N 0.000 claims description 9
- 150000001875 compounds Chemical group 0.000 claims description 9
- TZLVRPLSVNESQC-UHFFFAOYSA-N potassium azide Chemical compound [K+].[N-]=[N+]=[N-] TZLVRPLSVNESQC-UHFFFAOYSA-N 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 9
- 239000000243 solution Substances 0.000 claims description 9
- 239000003849 aromatic solvent Substances 0.000 claims description 8
- GUWHRJQTTVADPB-UHFFFAOYSA-N lithium azide Chemical compound [Li+].[N-]=[N+]=[N-] GUWHRJQTTVADPB-UHFFFAOYSA-N 0.000 claims description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 8
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 7
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 7
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 7
- 239000008096 xylene Substances 0.000 claims description 7
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 5
- 239000003513 alkali Substances 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 5
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 4
- 150000001540 azides Chemical class 0.000 claims description 4
- 229910052751 metal Inorganic materials 0.000 claims description 4
- 239000002184 metal Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- XGISHOFUAFNYQF-UHFFFAOYSA-N pentanoyl chloride Chemical compound CCCCC(Cl)=O XGISHOFUAFNYQF-UHFFFAOYSA-N 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 239000002253 acid Chemical class 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 229940125782 compound 2 Drugs 0.000 claims 3
- 229940125904 compound 1 Drugs 0.000 claims 2
- 239000002585 base Substances 0.000 claims 1
- 150000005323 carbonate salts Chemical class 0.000 claims 1
- 229940126214 compound 3 Drugs 0.000 claims 1
- 238000010931 ester hydrolysis Methods 0.000 claims 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 claims 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- 125000003944 tolyl group Chemical group 0.000 claims 1
- 239000002994 raw material Substances 0.000 abstract description 7
- 150000003606 tin compounds Chemical class 0.000 abstract description 3
- 238000003912 environmental pollution Methods 0.000 abstract description 2
- 238000009776 industrial production Methods 0.000 abstract 1
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 16
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 14
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 9
- 125000003118 aryl group Chemical group 0.000 description 8
- 235000005074 zinc chloride Nutrition 0.000 description 8
- 239000011592 zinc chloride Substances 0.000 description 8
- 235000019270 ammonium chloride Nutrition 0.000 description 7
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Natural products OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical group [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- 235000011181 potassium carbonates Nutrition 0.000 description 4
- 125000001424 substituent group Chemical group 0.000 description 4
- 239000002841 Lewis acid Substances 0.000 description 3
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 3
- 238000009833 condensation Methods 0.000 description 3
- 230000005494 condensation Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229960002089 ferrous chloride Drugs 0.000 description 3
- NMCUIPGRVMDVDB-UHFFFAOYSA-L iron dichloride Chemical compound Cl[Fe]Cl NMCUIPGRVMDVDB-UHFFFAOYSA-L 0.000 description 3
- 150000007517 lewis acids Chemical class 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- JNONJXMVMJSMTC-UHFFFAOYSA-N hydron;triethylazanium;sulfate Chemical compound OS(O)(=O)=O.CCN(CC)CC JNONJXMVMJSMTC-UHFFFAOYSA-N 0.000 description 2
- 235000006408 oxalic acid Nutrition 0.000 description 2
- 239000011736 potassium bicarbonate Substances 0.000 description 2
- 235000015497 potassium bicarbonate Nutrition 0.000 description 2
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 2
- SSOLNOMRVKKSON-UHFFFAOYSA-N proguanil Chemical compound CC(C)\N=C(/N)N=C(N)NC1=CC=C(Cl)C=C1 SSOLNOMRVKKSON-UHFFFAOYSA-N 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 235000017550 sodium carbonate Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- GOMLISZHRJBRGK-UHFFFAOYSA-N 2-(4-formylphenyl)benzonitrile Chemical group C1=CC(C=O)=CC=C1C1=CC=CC=C1C#N GOMLISZHRJBRGK-UHFFFAOYSA-N 0.000 description 1
- LFFIEVAMVPCZNA-UHFFFAOYSA-N 2-[4-(bromomethyl)phenyl]benzonitrile Chemical group C1=CC(CBr)=CC=C1C1=CC=CC=C1C#N LFFIEVAMVPCZNA-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical class NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical class CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 1
- 125000000319 biphenyl-4-yl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- HCFPRFJJTHMING-UHFFFAOYSA-N ethane-1,2-diamine;hydron;chloride Chemical compound [Cl-].NCC[NH3+] HCFPRFJJTHMING-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- DLDIDQIZPBIVNQ-UHFFFAOYSA-N hydron;2-methylpropan-2-amine;chloride Chemical compound Cl.CC(C)(C)N DLDIDQIZPBIVNQ-UHFFFAOYSA-N 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 150000003956 methylamines Chemical class 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- YBRBMKDOPFTVDT-UHFFFAOYSA-N tert-butylamine Chemical class CC(C)(C)N YBRBMKDOPFTVDT-UHFFFAOYSA-N 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 238000007039 two-step reaction Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007100383460A CN101270096B (zh) | 2007-03-22 | 2007-03-22 | 一种合成缬沙坦的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007100383460A CN101270096B (zh) | 2007-03-22 | 2007-03-22 | 一种合成缬沙坦的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101270096A CN101270096A (zh) | 2008-09-24 |
CN101270096B true CN101270096B (zh) | 2011-08-03 |
Family
ID=40004349
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007100383460A Active CN101270096B (zh) | 2007-03-22 | 2007-03-22 | 一种合成缬沙坦的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101270096B (zh) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI2556059T1 (sl) * | 2010-04-07 | 2014-07-31 | Krka, D.D., Novo Mesto | Izboljšan proces za pripravo valsartana |
CN101817795B (zh) * | 2010-05-13 | 2013-03-27 | 浙江美诺华药物化学有限公司 | 一种合成缬沙坦的改进方法 |
SG187007A1 (en) * | 2010-08-03 | 2013-02-28 | Novartis Ag | Highly crystalline valsartan |
CN102060797A (zh) * | 2010-12-31 | 2011-05-18 | 江苏江神药物化学有限公司 | 一种高纯度缬沙坦甲酯晶体的生产工艺 |
CN102649780A (zh) * | 2011-02-28 | 2012-08-29 | 广东东阳光药业有限公司 | 一种合成缬沙坦的改进工艺 |
CN102321038B (zh) * | 2011-07-11 | 2014-03-26 | 安徽省虹升生物科技有限公司 | 一种改进的制备缬沙坦方法 |
CN103613558B (zh) * | 2013-11-08 | 2015-10-21 | 浙江新赛科药业有限公司 | 一种缬沙坦的制备方法 |
CN103922528B (zh) * | 2014-03-21 | 2019-07-02 | 浙江华海药业股份有限公司 | 一种缬沙坦废水处理的方法 |
CN103923028B (zh) * | 2014-05-04 | 2017-05-24 | 青岛雪洁助剂有限公司 | 一种缬沙坦甲酯的制备方法 |
US11655220B2 (en) | 2020-10-22 | 2023-05-23 | Hetero Labs Limited | Process for the preparation of angiotensin II receptor blockers |
-
2007
- 2007-03-22 CN CN2007100383460A patent/CN101270096B/zh active Active
Non-Patent Citations (1)
Title |
---|
贾庆忠等.抗高血压药缬沙坦的合成.中国医药工业杂志.2001,32(9),385-387. * |
Also Published As
Publication number | Publication date |
---|---|
CN101270096A (zh) | 2008-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101270096B (zh) | 一种合成缬沙坦的方法 | |
JPH07188065A (ja) | デュロキシン中間体の不斉合成 | |
CN101362728A (zh) | 一种缬沙坦的合成方法 | |
WO2011035725A1 (zh) | 西他列汀中间体及其制备方法和用途 | |
CN101817795A (zh) | 一种合成缬沙坦的改进方法 | |
CN102964313A (zh) | 一种非布索坦的合成方法 | |
CN102276482A (zh) | 2-甲氧基-5-溴苯胺的制备方法 | |
CN102432523B (zh) | 一种3-羟基-3-芳基吲哚-2-酮衍生物的合成方法 | |
CN103923028B (zh) | 一种缬沙坦甲酯的制备方法 | |
CN100361977C (zh) | 1-烷基-3-氨基吲唑 | |
CN102304090A (zh) | 一种5-取代的苯硫基-苯并咪唑-2-n-甲氧基羰基化合物的制备方法 | |
US20090306397A1 (en) | Method for the production of substituted azoles | |
CN102417486A (zh) | 一种缬沙坦的合成方法 | |
CN100516025C (zh) | 一种用正戊酸合成d-正缬氨酸的方法 | |
CN106810452A (zh) | 一种盐酸西那卡塞的制备方法 | |
MX2012005025A (es) | Proceso para la elaboracion de compuestos organicos. | |
CN102838514B (zh) | 环己磺菌胺的合成方法 | |
CN105777734A (zh) | 一种利伐沙班中间体的合成方法 | |
CN103923058A (zh) | 一种合成维兰特罗中间体及其盐的方法 | |
CN104311471A (zh) | 一种改进的米格列奈钙的工业化制备方法 | |
CN102391203A (zh) | 制备6-取代的-1-甲基-1-h-苯并咪唑衍生物的方法及其合成中间体 | |
CN105949084A (zh) | 一种丁二腈的制备方法 | |
CN107602454B (zh) | 磺酰胺类化合物及其制备方法和用途 | |
CN101575301A (zh) | 一种2-氨基-5-氯苯甲酰胺的制备方法 | |
CN101153010A (zh) | 一种新的瑞格列奈关键中间体的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY Effective date: 20131125 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Shi Huilin Inventor after: Wang Liquan Inventor after: Chen Wei Inventor after: Liu Dapeng Inventor after: Zhou Hu Inventor after: Tu Guoliang Inventor before: Wang Liquan Inventor before: Chen Wei Inventor before: Liu Dapeng |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: WANG LIQUAN CHEN WEI LIU DAPENG TO: SHI HUILIN WANG LIQUAN CHEN WEI LIU DAPENG ZHOU HU TU GUOLIANG |
|
TR01 | Transfer of patent right |
Effective date of registration: 20131125 Address after: 317024 flood bridge, Linhai City, Zhejiang Patentee after: Zhejiang Huahai Pharmaceutical Co., Ltd. Patentee after: Shanghai Institute of pharmaceutical industry Address before: 317024, Zhejiang province Linhai City Xun Town Li Zhuang Patentee before: Zhejiang Huahai Pharmaceutical Co., Ltd. |
|
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Liquan Inventor after: Chen Wei Inventor after: Liu Dapeng Inventor before: Shi Huilin Inventor before: Wang Liquan Inventor before: Chen Wei Inventor before: Liu Dapeng Inventor before: Zhou Hu Inventor before: Tu Guoliang |
|
COR | Change of bibliographic data | ||
TR01 | Transfer of patent right |
Effective date of registration: 20151117 Address after: 317024 flood bridge, Linhai City, Zhejiang Patentee after: Zhejiang Huahai Pharmaceutical Co., Ltd. Address before: 317024 flood bridge, Linhai City, Zhejiang Patentee before: Zhejiang Huahai Pharmaceutical Co., Ltd. Patentee before: Shanghai Institute of pharmaceutical industry |